Organization
Changchun BCHT Biotechnology
3 clinical trials
Clinical trial
Multi-center, Randomized, Double-blind, Placebo-controlled Trial of a Live Attenuated Influenza Vaccine in People Aged 3-17Status: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
Multicenter, Randomized, Blinded, Controlled Phase I / Clinical Trial Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of the Fully Human Anti-tetanus Toxin Monoclonal Antibody A82 / B86 Injection CombinationStatus: Not yet recruiting, Estimated PCD: 2024-10-30
Clinical trial
Multicenter, Randomized, Double-blind, Placebo / Positive Control Evaluation of the First Safety, Pharmacokinetic and Pharmacodynamic Phase I Clinical Trial of Rabies Monomab CBB 1 in Healthy PeopleStatus: Not yet recruiting, Estimated PCD: 2023-12-30